ATE517999T1 - Adenovirale vektoren zur behandlung der erkrankungen - Google Patents
Adenovirale vektoren zur behandlung der erkrankungenInfo
- Publication number
- ATE517999T1 ATE517999T1 AT99918712T AT99918712T ATE517999T1 AT E517999 T1 ATE517999 T1 AT E517999T1 AT 99918712 T AT99918712 T AT 99918712T AT 99918712 T AT99918712 T AT 99918712T AT E517999 T1 ATE517999 T1 AT E517999T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- adenoviral
- adenoviral vectors
- diseases
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04001—Cytosine deaminase (3.5.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8303398P | 1998-04-24 | 1998-04-24 | |
US11710399P | 1999-01-25 | 1999-01-25 | |
PCT/US1999/008656 WO1999055831A2 (en) | 1998-04-24 | 1999-04-19 | Adenoviral vectors for treating disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE517999T1 true ATE517999T1 (de) | 2011-08-15 |
Family
ID=26768867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99918712T ATE517999T1 (de) | 1998-04-24 | 1999-04-19 | Adenovirale vektoren zur behandlung der erkrankungen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1071805B1 (de) |
JP (1) | JP2002512785A (de) |
CN (1) | CN1298451A (de) |
AT (1) | ATE517999T1 (de) |
AU (1) | AU772963B2 (de) |
CA (1) | CA2323235A1 (de) |
CY (1) | CY1111931T1 (de) |
DK (1) | DK1071805T3 (de) |
PT (1) | PT1071805E (de) |
WO (1) | WO1999055831A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1218527A2 (de) * | 1999-07-02 | 2002-07-03 | Onyx Pharmaceuticals, Inc. | Adenovirenvektoren zur behandlung der erkrankungen |
US6579522B1 (en) | 2000-06-27 | 2003-06-17 | Genvec, Inc. | Replication deficient adenoviral TNF vector |
WO2002068627A2 (en) | 2001-02-23 | 2002-09-06 | Novartis Ag | Vector constucts |
US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
CN100361710C (zh) * | 2004-06-07 | 2008-01-16 | 成都康弘生物科技有限公司 | 肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用 |
CN1328372C (zh) * | 2005-05-25 | 2007-07-25 | 上海希元生物技术有限公司 | 肿瘤靶向基因-病毒zd55-il-24及其构建方法和应用 |
WO2011014794A1 (en) * | 2009-07-31 | 2011-02-03 | Paxvax, Inc. | Adenoviral-based vectors |
CN102174479B (zh) * | 2011-03-02 | 2013-04-03 | 北京锤特生物科技有限公司 | 靶向性治疗人肿瘤的溶肿瘤腺病毒及其应用 |
KR101427200B1 (ko) | 2011-11-24 | 2014-08-07 | 주식회사 바이로메드 | 아데노바이러스 생산 신규 세포주 및 그의 용도 |
EP2970945B1 (de) * | 2013-03-14 | 2024-05-01 | GenVivo, Inc. | Verbessertes thymidinkinasegen |
NZ759833A (en) * | 2017-05-26 | 2023-01-27 | Epicentrx Inc | Recombinant adenoviruses carrying transgenes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585362A (en) * | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
US6780406B1 (en) * | 1994-03-21 | 2004-08-24 | The Regents Of The University Of Michigan | Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
-
1999
- 1999-04-19 EP EP99918712A patent/EP1071805B1/de not_active Expired - Lifetime
- 1999-04-19 JP JP2000545977A patent/JP2002512785A/ja active Pending
- 1999-04-19 AU AU36563/99A patent/AU772963B2/en not_active Ceased
- 1999-04-19 WO PCT/US1999/008656 patent/WO1999055831A2/en active IP Right Grant
- 1999-04-19 DK DK99918712.3T patent/DK1071805T3/da active
- 1999-04-19 AT AT99918712T patent/ATE517999T1/de active
- 1999-04-19 CN CN99805402A patent/CN1298451A/zh active Pending
- 1999-04-19 PT PT99918712T patent/PT1071805E/pt unknown
- 1999-04-19 CA CA002323235A patent/CA2323235A1/en not_active Abandoned
-
2011
- 2011-10-11 CY CY20111100974T patent/CY1111931T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1071805T3 (da) | 2011-09-26 |
EP1071805B1 (de) | 2011-07-27 |
JP2002512785A (ja) | 2002-05-08 |
CN1298451A (zh) | 2001-06-06 |
AU772963B2 (en) | 2004-05-13 |
EP1071805A2 (de) | 2001-01-31 |
AU3656399A (en) | 1999-11-16 |
WO1999055831A3 (en) | 2000-03-30 |
WO1999055831A2 (en) | 1999-11-04 |
CA2323235A1 (en) | 1999-11-04 |
PT1071805E (pt) | 2011-10-04 |
CY1111931T1 (el) | 2015-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111931T1 (el) | Φορεις αδενοϊων για την αγωγη νοσου | |
ATE380195T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
WO1999035170A8 (en) | Compositions and methods for the treatment of tumor | |
JPH10508188A (ja) | 細胞周期調節リプレッサーおよびdnaエレメント | |
Lin et al. | Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers | |
WO2000053755A3 (en) | Compositions and methods for the treatment of tumor | |
IL126557A0 (en) | Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors | |
CY1105240T1 (el) | 5’ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ | |
PENG et al. | c‐myc gene abnormalities in mucosa‐associated lymphoid tissue (MALT) lymphomas | |
ATE488529T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
DE60132190D1 (de) | Mutierte version der arginin deiminase | |
Suzuki et al. | State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer | |
EP1642907A3 (de) | Zusammensetzung und Verfahren zur Diagnose von Tumoren | |
WO2001002540A3 (en) | Adenoviral vectors for treating disease | |
Nomoto et al. | Structural basis for the regulation of UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells | |
WO2004075835A3 (en) | Methods for the treatment of renal cell carcinoma | |
Hussein et al. | Building bridges in cancer: mismatch repair and microsatellite instability | |
Fogt et al. | Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinoma. | |
KR960034416A (ko) | 아폽토시스 조절 유전자 | |
Yamamoto et al. | p73 is highly expressed in myoepithelial cells and in carcinomas with metaplasia | |
Liang | p53 proteins and aflatoxin b1: the good, the bad, and the ugly | |
WO2002042460A3 (en) | Compositions and methods relating to colon specific genes and proteins | |
Telling | Genetic analysis of the functions of the adenovirus E1 proteins in oncogenic transformation and lytic infection. | |
Mukhopadhyay et al. | In vitro binding of cattle Pst I SINE with a 33-kDa nuclear protein | |
Boccia | The characterization of a distal element in the factor IX gene: a study of site five. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1071805 Country of ref document: EP |